nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Vincristine—muscle cancer	0.107	0.147	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.107	0.147	CbGbCtD
Nefazodone—ABCB1—Dactinomycin—muscle cancer	0.0846	0.117	CbGbCtD
Nefazodone—CYP3A5—Vincristine—muscle cancer	0.08	0.11	CbGbCtD
Nefazodone—CYP3A5—Etoposide—muscle cancer	0.0733	0.101	CbGbCtD
Nefazodone—ABCB1—Vincristine—muscle cancer	0.0521	0.0718	CbGbCtD
Nefazodone—ABCB1—Etoposide—muscle cancer	0.0477	0.0658	CbGbCtD
Nefazodone—ABCB1—Doxorubicin—muscle cancer	0.0325	0.0449	CbGbCtD
Nefazodone—ABCB1—Methotrexate—muscle cancer	0.0315	0.0435	CbGbCtD
Nefazodone—CYP3A4—Vincristine—muscle cancer	0.0312	0.043	CbGbCtD
Nefazodone—CYP2D6—Doxorubicin—muscle cancer	0.0307	0.0423	CbGbCtD
Nefazodone—CYP3A4—Etoposide—muscle cancer	0.0286	0.0394	CbGbCtD
Nefazodone—CYP3A4—Doxorubicin—muscle cancer	0.0195	0.0269	CbGbCtD
Nefazodone—Hepatic failure—Doxorubicin—muscle cancer	0.00066	0.0024	CcSEcCtD
Nefazodone—Eye pain—Doxorubicin—muscle cancer	0.000657	0.00239	CcSEcCtD
Nefazodone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000654	0.00238	CcSEcCtD
Nefazodone—Mood swings—Methotrexate—muscle cancer	0.000649	0.00236	CcSEcCtD
Nefazodone—Hypotension—Vincristine—muscle cancer	0.000649	0.00236	CcSEcCtD
Nefazodone—Ataxia—Methotrexate—muscle cancer	0.000644	0.00234	CcSEcCtD
Nefazodone—Feeling abnormal—Dactinomycin—muscle cancer	0.00064	0.00233	CcSEcCtD
Nefazodone—Ill-defined disorder—Etoposide—muscle cancer	0.000639	0.00233	CcSEcCtD
Nefazodone—Anaemia—Etoposide—muscle cancer	0.000637	0.00232	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000635	0.00231	CcSEcCtD
Nefazodone—Liver function test abnormal—Methotrexate—muscle cancer	0.000633	0.0023	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000633	0.0023	CcSEcCtD
Nefazodone—Increased appetite—Doxorubicin—muscle cancer	0.000632	0.0023	CcSEcCtD
Nefazodone—Insomnia—Vincristine—muscle cancer	0.000628	0.00228	CcSEcCtD
Nefazodone—Paraesthesia—Vincristine—muscle cancer	0.000623	0.00227	CcSEcCtD
Nefazodone—Malaise—Etoposide—muscle cancer	0.000621	0.00226	CcSEcCtD
Nefazodone—Dermatitis bullous—Doxorubicin—muscle cancer	0.000621	0.00226	CcSEcCtD
Nefazodone—Vertigo—Etoposide—muscle cancer	0.000619	0.00225	CcSEcCtD
Nefazodone—Leukopenia—Etoposide—muscle cancer	0.000617	0.00224	CcSEcCtD
Nefazodone—Abdominal pain—Dactinomycin—muscle cancer	0.000614	0.00223	CcSEcCtD
Nefazodone—Body temperature increased—Dactinomycin—muscle cancer	0.000614	0.00223	CcSEcCtD
Nefazodone—Hypoglycaemia—Doxorubicin—muscle cancer	0.000608	0.00221	CcSEcCtD
Nefazodone—Loss of consciousness—Etoposide—muscle cancer	0.000606	0.0022	CcSEcCtD
Nefazodone—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000606	0.0022	CcSEcCtD
Nefazodone—Decreased appetite—Vincristine—muscle cancer	0.000604	0.0022	CcSEcCtD
Nefazodone—Cough—Etoposide—muscle cancer	0.000601	0.00219	CcSEcCtD
Nefazodone—Convulsion—Etoposide—muscle cancer	0.000597	0.00217	CcSEcCtD
Nefazodone—Hyponatraemia—Doxorubicin—muscle cancer	0.000596	0.00217	CcSEcCtD
Nefazodone—Hypertension—Etoposide—muscle cancer	0.000595	0.00216	CcSEcCtD
Nefazodone—Constipation—Vincristine—muscle cancer	0.000594	0.00216	CcSEcCtD
Nefazodone—Pain—Vincristine—muscle cancer	0.000594	0.00216	CcSEcCtD
Nefazodone—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000593	0.00216	CcSEcCtD
Nefazodone—Diplopia—Doxorubicin—muscle cancer	0.000593	0.00216	CcSEcCtD
Nefazodone—Osteoarthritis—Doxorubicin—muscle cancer	0.000593	0.00216	CcSEcCtD
Nefazodone—Asthma—Methotrexate—muscle cancer	0.000592	0.00215	CcSEcCtD
Nefazodone—Chest pain—Etoposide—muscle cancer	0.000587	0.00213	CcSEcCtD
Nefazodone—Affect lability—Doxorubicin—muscle cancer	0.000584	0.00213	CcSEcCtD
Nefazodone—Migraine—Doxorubicin—muscle cancer	0.000584	0.00213	CcSEcCtD
Nefazodone—Discomfort—Etoposide—muscle cancer	0.00058	0.00211	CcSEcCtD
Nefazodone—Face oedema—Doxorubicin—muscle cancer	0.000573	0.00208	CcSEcCtD
Nefazodone—Hypersensitivity—Dactinomycin—muscle cancer	0.000573	0.00208	CcSEcCtD
Nefazodone—Gastrointestinal pain—Vincristine—muscle cancer	0.000568	0.00207	CcSEcCtD
Nefazodone—Confusional state—Etoposide—muscle cancer	0.000567	0.00206	CcSEcCtD
Nefazodone—Anaphylactic shock—Etoposide—muscle cancer	0.000562	0.00205	CcSEcCtD
Nefazodone—Mood swings—Doxorubicin—muscle cancer	0.000562	0.00205	CcSEcCtD
Nefazodone—Infection—Etoposide—muscle cancer	0.000559	0.00203	CcSEcCtD
Nefazodone—Ataxia—Doxorubicin—muscle cancer	0.000558	0.00203	CcSEcCtD
Nefazodone—Asthenia—Dactinomycin—muscle cancer	0.000558	0.00203	CcSEcCtD
Nefazodone—Dysuria—Methotrexate—muscle cancer	0.000554	0.00202	CcSEcCtD
Nefazodone—Dehydration—Doxorubicin—muscle cancer	0.000552	0.00201	CcSEcCtD
Nefazodone—Thrombocytopenia—Etoposide—muscle cancer	0.000551	0.002	CcSEcCtD
Nefazodone—Tachycardia—Etoposide—muscle cancer	0.000549	0.002	CcSEcCtD
Nefazodone—Abdominal pain—Vincristine—muscle cancer	0.000549	0.002	CcSEcCtD
Nefazodone—Body temperature increased—Vincristine—muscle cancer	0.000549	0.002	CcSEcCtD
Nefazodone—Liver function test abnormal—Doxorubicin—muscle cancer	0.000548	0.00199	CcSEcCtD
Nefazodone—Erectile dysfunction—Methotrexate—muscle cancer	0.000546	0.00198	CcSEcCtD
Nefazodone—Dry skin—Doxorubicin—muscle cancer	0.000544	0.00198	CcSEcCtD
Nefazodone—Hyperhidrosis—Etoposide—muscle cancer	0.000544	0.00198	CcSEcCtD
Nefazodone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000542	0.00197	CcSEcCtD
Nefazodone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000541	0.00197	CcSEcCtD
Nefazodone—Anorexia—Etoposide—muscle cancer	0.000536	0.00195	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000534	0.00194	CcSEcCtD
Nefazodone—Diarrhoea—Dactinomycin—muscle cancer	0.000532	0.00193	CcSEcCtD
Nefazodone—Pneumonia—Methotrexate—muscle cancer	0.000531	0.00193	CcSEcCtD
Nefazodone—Hypotension—Etoposide—muscle cancer	0.000526	0.00191	CcSEcCtD
Nefazodone—Gastritis—Doxorubicin—muscle cancer	0.000525	0.00191	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000524	0.0019	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000523	0.0019	CcSEcCtD
Nefazodone—Abdominal distension—Doxorubicin—muscle cancer	0.000516	0.00188	CcSEcCtD
Nefazodone—Stomatitis—Methotrexate—muscle cancer	0.000515	0.00187	CcSEcCtD
Nefazodone—Conjunctivitis—Methotrexate—muscle cancer	0.000513	0.00187	CcSEcCtD
Nefazodone—Dysphagia—Doxorubicin—muscle cancer	0.000513	0.00187	CcSEcCtD
Nefazodone—Influenza—Doxorubicin—muscle cancer	0.000513	0.00187	CcSEcCtD
Nefazodone—Asthma—Doxorubicin—muscle cancer	0.000513	0.00187	CcSEcCtD
Nefazodone—Hypersensitivity—Vincristine—muscle cancer	0.000512	0.00186	CcSEcCtD
Nefazodone—Sweating—Methotrexate—muscle cancer	0.000506	0.00184	CcSEcCtD
Nefazodone—Paraesthesia—Etoposide—muscle cancer	0.000505	0.00184	CcSEcCtD
Nefazodone—Haematuria—Methotrexate—muscle cancer	0.000504	0.00183	CcSEcCtD
Nefazodone—Dyspnoea—Etoposide—muscle cancer	0.000501	0.00182	CcSEcCtD
Nefazodone—Somnolence—Etoposide—muscle cancer	0.0005	0.00182	CcSEcCtD
Nefazodone—Angina pectoris—Doxorubicin—muscle cancer	0.0005	0.00182	CcSEcCtD
Nefazodone—Epistaxis—Methotrexate—muscle cancer	0.000498	0.00181	CcSEcCtD
Nefazodone—Asthenia—Vincristine—muscle cancer	0.000498	0.00181	CcSEcCtD
Nefazodone—Vomiting—Dactinomycin—muscle cancer	0.000494	0.0018	CcSEcCtD
Nefazodone—Bronchitis—Doxorubicin—muscle cancer	0.000493	0.00179	CcSEcCtD
Nefazodone—Rash—Dactinomycin—muscle cancer	0.00049	0.00178	CcSEcCtD
Nefazodone—Decreased appetite—Etoposide—muscle cancer	0.000489	0.00178	CcSEcCtD
Nefazodone—Pain—Etoposide—muscle cancer	0.000481	0.00175	CcSEcCtD
Nefazodone—Constipation—Etoposide—muscle cancer	0.000481	0.00175	CcSEcCtD
Nefazodone—Dysuria—Doxorubicin—muscle cancer	0.00048	0.00174	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—muscle cancer	0.000477	0.00173	CcSEcCtD
Nefazodone—Diarrhoea—Vincristine—muscle cancer	0.000475	0.00173	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—muscle cancer	0.000474	0.00172	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—muscle cancer	0.000474	0.00172	CcSEcCtD
Nefazodone—Pollakiuria—Doxorubicin—muscle cancer	0.000474	0.00172	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—muscle cancer	0.000471	0.00171	CcSEcCtD
Nefazodone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000468	0.0017	CcSEcCtD
Nefazodone—Weight increased—Doxorubicin—muscle cancer	0.000467	0.0017	CcSEcCtD
Nefazodone—Weight decreased—Doxorubicin—muscle cancer	0.000464	0.00169	CcSEcCtD
Nefazodone—Feeling abnormal—Etoposide—muscle cancer	0.000463	0.00169	CcSEcCtD
Nefazodone—Nausea—Dactinomycin—muscle cancer	0.000462	0.00168	CcSEcCtD
Nefazodone—Pneumonia—Doxorubicin—muscle cancer	0.00046	0.00167	CcSEcCtD
Nefazodone—Gastrointestinal pain—Etoposide—muscle cancer	0.00046	0.00167	CcSEcCtD
Nefazodone—Dizziness—Vincristine—muscle cancer	0.000459	0.00167	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—muscle cancer	0.000457	0.00166	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000453	0.00165	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—muscle cancer	0.000448	0.00163	CcSEcCtD
Nefazodone—Urticaria—Etoposide—muscle cancer	0.000447	0.00163	CcSEcCtD
Nefazodone—Stomatitis—Doxorubicin—muscle cancer	0.000446	0.00162	CcSEcCtD
Nefazodone—Abdominal pain—Etoposide—muscle cancer	0.000445	0.00162	CcSEcCtD
Nefazodone—Body temperature increased—Etoposide—muscle cancer	0.000445	0.00162	CcSEcCtD
Nefazodone—Conjunctivitis—Doxorubicin—muscle cancer	0.000445	0.00162	CcSEcCtD
Nefazodone—Urinary tract infection—Doxorubicin—muscle cancer	0.000445	0.00162	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—muscle cancer	0.000442	0.00161	CcSEcCtD
Nefazodone—Vomiting—Vincristine—muscle cancer	0.000441	0.00161	CcSEcCtD
Nefazodone—Sweating—Doxorubicin—muscle cancer	0.000438	0.0016	CcSEcCtD
Nefazodone—Rash—Vincristine—muscle cancer	0.000438	0.00159	CcSEcCtD
Nefazodone—Dermatitis—Vincristine—muscle cancer	0.000437	0.00159	CcSEcCtD
Nefazodone—Haematuria—Doxorubicin—muscle cancer	0.000436	0.00159	CcSEcCtD
Nefazodone—Headache—Vincristine—muscle cancer	0.000435	0.00158	CcSEcCtD
Nefazodone—Epistaxis—Doxorubicin—muscle cancer	0.000431	0.00157	CcSEcCtD
Nefazodone—Sinusitis—Doxorubicin—muscle cancer	0.000429	0.00156	CcSEcCtD
Nefazodone—Chills—Methotrexate—muscle cancer	0.000425	0.00155	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—muscle cancer	0.000419	0.00152	CcSEcCtD
Nefazodone—Bradycardia—Doxorubicin—muscle cancer	0.000418	0.00152	CcSEcCtD
Nefazodone—Hypersensitivity—Etoposide—muscle cancer	0.000414	0.00151	CcSEcCtD
Nefazodone—Haemoglobin—Doxorubicin—muscle cancer	0.000413	0.0015	CcSEcCtD
Nefazodone—Nausea—Vincristine—muscle cancer	0.000412	0.0015	CcSEcCtD
Nefazodone—Rhinitis—Doxorubicin—muscle cancer	0.000412	0.0015	CcSEcCtD
Nefazodone—Haemorrhage—Doxorubicin—muscle cancer	0.000411	0.00149	CcSEcCtD
Nefazodone—Hepatitis—Doxorubicin—muscle cancer	0.000411	0.00149	CcSEcCtD
Nefazodone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000409	0.00149	CcSEcCtD
Nefazodone—Pharyngitis—Doxorubicin—muscle cancer	0.000407	0.00148	CcSEcCtD
Nefazodone—Oedema peripheral—Doxorubicin—muscle cancer	0.000404	0.00147	CcSEcCtD
Nefazodone—Dysgeusia—Methotrexate—muscle cancer	0.000404	0.00147	CcSEcCtD
Nefazodone—Asthenia—Etoposide—muscle cancer	0.000404	0.00147	CcSEcCtD
Nefazodone—Back pain—Methotrexate—muscle cancer	0.000399	0.00145	CcSEcCtD
Nefazodone—Pruritus—Etoposide—muscle cancer	0.000398	0.00145	CcSEcCtD
Nefazodone—Visual impairment—Doxorubicin—muscle cancer	0.000396	0.00144	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—muscle cancer	0.000389	0.00142	CcSEcCtD
Nefazodone—Erythema multiforme—Doxorubicin—muscle cancer	0.000388	0.00141	CcSEcCtD
Nefazodone—Diarrhoea—Etoposide—muscle cancer	0.000385	0.0014	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—muscle cancer	0.000383	0.00139	CcSEcCtD
Nefazodone—Tinnitus—Doxorubicin—muscle cancer	0.000383	0.00139	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—muscle cancer	0.000381	0.00139	CcSEcCtD
Nefazodone—Flushing—Doxorubicin—muscle cancer	0.000381	0.00139	CcSEcCtD
Nefazodone—Malaise—Methotrexate—muscle cancer	0.000372	0.00135	CcSEcCtD
Nefazodone—Dizziness—Etoposide—muscle cancer	0.000372	0.00135	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—muscle cancer	0.000371	0.00135	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—muscle cancer	0.000369	0.00134	CcSEcCtD
Nefazodone—Chills—Doxorubicin—muscle cancer	0.000368	0.00134	CcSEcCtD
Nefazodone—Alopecia—Doxorubicin—muscle cancer	0.000363	0.00132	CcSEcCtD
Nefazodone—Cough—Methotrexate—muscle cancer	0.00036	0.00131	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—muscle cancer	0.000358	0.0013	CcSEcCtD
Nefazodone—Vomiting—Etoposide—muscle cancer	0.000358	0.0013	CcSEcCtD
Nefazodone—Rash—Etoposide—muscle cancer	0.000355	0.00129	CcSEcCtD
Nefazodone—Dermatitis—Etoposide—muscle cancer	0.000354	0.00129	CcSEcCtD
Nefazodone—Headache—Etoposide—muscle cancer	0.000352	0.00128	CcSEcCtD
Nefazodone—Flatulence—Doxorubicin—muscle cancer	0.000352	0.00128	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—muscle cancer	0.000351	0.00128	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—muscle cancer	0.000351	0.00128	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—muscle cancer	0.000351	0.00128	CcSEcCtD
Nefazodone—Dysgeusia—Doxorubicin—muscle cancer	0.00035	0.00127	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—muscle cancer	0.000347	0.00126	CcSEcCtD
Nefazodone—Back pain—Doxorubicin—muscle cancer	0.000346	0.00126	CcSEcCtD
Nefazodone—Muscle spasms—Doxorubicin—muscle cancer	0.000344	0.00125	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—muscle cancer	0.00034	0.00124	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—muscle cancer	0.000337	0.00123	CcSEcCtD
Nefazodone—Vision blurred—Doxorubicin—muscle cancer	0.000337	0.00123	CcSEcCtD
Nefazodone—Infection—Methotrexate—muscle cancer	0.000335	0.00122	CcSEcCtD
Nefazodone—Nausea—Etoposide—muscle cancer	0.000334	0.00122	CcSEcCtD
Nefazodone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000332	0.00121	CcSEcCtD
Nefazodone—Anaemia—Doxorubicin—muscle cancer	0.00033	0.0012	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—muscle cancer	0.00033	0.0012	CcSEcCtD
Nefazodone—Agitation—Doxorubicin—muscle cancer	0.000328	0.00119	CcSEcCtD
Nefazodone—Hyperhidrosis—Methotrexate—muscle cancer	0.000326	0.00118	CcSEcCtD
Nefazodone—Malaise—Doxorubicin—muscle cancer	0.000322	0.00117	CcSEcCtD
Nefazodone—Vertigo—Doxorubicin—muscle cancer	0.000321	0.00117	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—muscle cancer	0.000321	0.00117	CcSEcCtD
Nefazodone—Syncope—Doxorubicin—muscle cancer	0.000321	0.00117	CcSEcCtD
Nefazodone—Leukopenia—Doxorubicin—muscle cancer	0.00032	0.00116	CcSEcCtD
Nefazodone—Palpitations—Doxorubicin—muscle cancer	0.000316	0.00115	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—muscle cancer	0.000315	0.00115	CcSEcCtD
Nefazodone—Loss of consciousness—Doxorubicin—muscle cancer	0.000314	0.00114	CcSEcCtD
Nefazodone—Cough—Doxorubicin—muscle cancer	0.000312	0.00113	CcSEcCtD
Nefazodone—Convulsion—Doxorubicin—muscle cancer	0.00031	0.00113	CcSEcCtD
Nefazodone—Hypertension—Doxorubicin—muscle cancer	0.000309	0.00112	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000307	0.00112	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—muscle cancer	0.000305	0.00111	CcSEcCtD
Nefazodone—Myalgia—Doxorubicin—muscle cancer	0.000304	0.00111	CcSEcCtD
Nefazodone—Chest pain—Doxorubicin—muscle cancer	0.000304	0.00111	CcSEcCtD
Nefazodone—Arthralgia—Doxorubicin—muscle cancer	0.000304	0.00111	CcSEcCtD
Nefazodone—Anxiety—Doxorubicin—muscle cancer	0.000303	0.0011	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—muscle cancer	0.000302	0.0011	CcSEcCtD
Nefazodone—Discomfort—Doxorubicin—muscle cancer	0.000301	0.00109	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—muscle cancer	0.0003	0.00109	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—muscle cancer	0.000299	0.00109	CcSEcCtD
Nefazodone—Dry mouth—Doxorubicin—muscle cancer	0.000298	0.00108	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—muscle cancer	0.000297	0.00108	CcSEcCtD
Nefazodone—Confusional state—Doxorubicin—muscle cancer	0.000294	0.00107	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—muscle cancer	0.000293	0.00107	CcSEcCtD
Nefazodone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000292	0.00106	CcSEcCtD
Nefazodone—Oedema—Doxorubicin—muscle cancer	0.000292	0.00106	CcSEcCtD
Nefazodone—Infection—Doxorubicin—muscle cancer	0.00029	0.00105	CcSEcCtD
Nefazodone—Pain—Methotrexate—muscle cancer	0.000288	0.00105	CcSEcCtD
Nefazodone—Shock—Doxorubicin—muscle cancer	0.000287	0.00104	CcSEcCtD
Nefazodone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000286	0.00104	CcSEcCtD
Nefazodone—Tachycardia—Doxorubicin—muscle cancer	0.000285	0.00104	CcSEcCtD
Nefazodone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000282	0.00103	CcSEcCtD
Nefazodone—Anorexia—Doxorubicin—muscle cancer	0.000278	0.00101	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—muscle cancer	0.000278	0.00101	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000275	0.001	CcSEcCtD
Nefazodone—Hypotension—Doxorubicin—muscle cancer	0.000273	0.000992	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—muscle cancer	0.000268	0.000974	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—muscle cancer	0.000266	0.000969	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—muscle cancer	0.000266	0.000969	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000266	0.000967	CcSEcCtD
Nefazodone—Insomnia—Doxorubicin—muscle cancer	0.000264	0.00096	CcSEcCtD
Nefazodone—Paraesthesia—Doxorubicin—muscle cancer	0.000262	0.000953	CcSEcCtD
Nefazodone—Dyspnoea—Doxorubicin—muscle cancer	0.00026	0.000946	CcSEcCtD
Nefazodone—Somnolence—Doxorubicin—muscle cancer	0.000259	0.000943	CcSEcCtD
Nefazodone—Dyspepsia—Doxorubicin—muscle cancer	0.000257	0.000934	CcSEcCtD
Nefazodone—Decreased appetite—Doxorubicin—muscle cancer	0.000254	0.000922	CcSEcCtD
Nefazodone—Constipation—Doxorubicin—muscle cancer	0.000249	0.000907	CcSEcCtD
Nefazodone—Pain—Doxorubicin—muscle cancer	0.000249	0.000907	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—muscle cancer	0.000248	0.000903	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—muscle cancer	0.000242	0.000879	CcSEcCtD
Nefazodone—Feeling abnormal—Doxorubicin—muscle cancer	0.00024	0.000874	CcSEcCtD
Nefazodone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000239	0.000868	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—muscle cancer	0.000238	0.000867	CcSEcCtD
Nefazodone—Urticaria—Doxorubicin—muscle cancer	0.000232	0.000843	CcSEcCtD
Nefazodone—Abdominal pain—Doxorubicin—muscle cancer	0.000231	0.000839	CcSEcCtD
Nefazodone—Body temperature increased—Doxorubicin—muscle cancer	0.000231	0.000839	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—muscle cancer	0.00023	0.000838	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—muscle cancer	0.000223	0.00081	CcSEcCtD
Nefazodone—Hypersensitivity—Doxorubicin—muscle cancer	0.000215	0.000782	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—muscle cancer	0.000214	0.000779	CcSEcCtD
Nefazodone—Rash—Methotrexate—muscle cancer	0.000212	0.000773	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—muscle cancer	0.000212	0.000772	CcSEcCtD
Nefazodone—Headache—Methotrexate—muscle cancer	0.000211	0.000768	CcSEcCtD
Nefazodone—Asthenia—Doxorubicin—muscle cancer	0.000209	0.000761	CcSEcCtD
Nefazodone—Pruritus—Doxorubicin—muscle cancer	0.000206	0.000751	CcSEcCtD
Nefazodone—Nausea—Methotrexate—muscle cancer	0.0002	0.000728	CcSEcCtD
Nefazodone—Diarrhoea—Doxorubicin—muscle cancer	0.0002	0.000726	CcSEcCtD
Nefazodone—Dizziness—Doxorubicin—muscle cancer	0.000193	0.000702	CcSEcCtD
Nefazodone—Vomiting—Doxorubicin—muscle cancer	0.000185	0.000675	CcSEcCtD
Nefazodone—Rash—Doxorubicin—muscle cancer	0.000184	0.000669	CcSEcCtD
Nefazodone—Dermatitis—Doxorubicin—muscle cancer	0.000184	0.000668	CcSEcCtD
Nefazodone—Headache—Doxorubicin—muscle cancer	0.000183	0.000665	CcSEcCtD
Nefazodone—Nausea—Doxorubicin—muscle cancer	0.000173	0.00063	CcSEcCtD
